As individual lawsuits continue to be filed in the U.S., makers of Invokana face a class action lawsuit in Canada over a potentially fatal risk of kidney failure associated with the diabetes drug. Seeking an Invokana recall throughout the country, the class is alleging that Johnson & Johnson’s subsidiary Janssen Pharmaceuticals failed to provide adequate warnings about Invokana’s risks to patients.
Attorneys at the law firm of Grant & Eisenhofer are similarly investigating claims against Janssen as a mass tort. While similar to a class action in that both mechanisms involve many plaintiffs with similar claims, in a mass tort cases remain their own separate individual actions, whereas in a class action all plaintiffs are represented by only one or a few individuals. Click here to learn more about the difference, or call 888-973-6379 if you experienced complications from taking Invokana and think you may have a claim against Janssen.